Comparison between Gujarat Kidney IPO and PhysicsWallah IPO.
Gujarat Kidney IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while PhysicsWallah IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Gujarat Kidney IPO is up to ₹250.80 Cr whereas the issue size of the PhysicsWallah IPO is up to ₹3,480.00 Cr. The final issue price of Gujarat Kidney IPO is ₹114.00 per share and of PhysicsWallah IPO is ₹109.00 per share.
| Gujarat Kidney IPO | PhysicsWallah IPO | |
|---|---|---|
| Face Value | ₹2 per share | ₹1 per share |
| Issue Price (Lower) | ₹108.00 per share | ₹103.00 per share |
| Issue Price (Upper) | ₹114.00 per share | ₹109.00 per share |
| Issue Price (Final) | ₹114.00 per share | ₹109.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ₹10.00 per share | |
| Market Lot Size | 128 shares | 137 shares |
| Fresh Issue Size | 2,20,00,000 shares | 28,44,68,537 shares |
| Fresh Issue Size (Amount) | up to ₹250.80 Cr | up to ₹3,100.08 Cr |
| OFS Issue Size | 0 shares | 3,48,62,384 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹379.92 Cr |
| Issue Size Total | 2,20,00,000 shares | 31,93,30,921 shares |
| Issue Size Total (Amount) | up to ₹250.80 Cr | up to ₹3,480.00 Cr |
Gujarat Kidney IPO opens on Dec 22, 2025, while PhysicsWallah IPO opens on Nov 11, 2025. The closing date of Gujarat Kidney IPO and PhysicsWallah IPO is Dec 24, 2025, and Nov 13, 2025, respectively.
| Gujarat Kidney IPO | PhysicsWallah IPO | |
|---|---|---|
| Anchor Bid Date | Dec 19, 2025 | Nov 10, 2025 |
| Issue Open | Dec 22, 2025 | Nov 11, 2025 |
| Issue Close | Dec 24, 2025 | Nov 13, 2025 |
| Basis Of Allotment (Tentative) | Dec 26, 2025 | Nov 14, 2025 |
| Initiation of Refunds (Tentative) | Dec 29, 2025 | Nov 17, 2025 |
| Credit of Share (Tentative) | Dec 29, 2025 | Nov 17, 2025 |
| Listing date (Tentative) | Dec 30, 2025 | Nov 18, 2025 |
| Anchor Lockin End date 1 | Jan 24, 2026 | Dec 13, 2025 |
| Anchor Lockin End date 2 | Mar 25, 2026 | Feb 11, 2026 |
Gujarat Kidney IPO P/E ratio is 61.62, as compared to PhysicsWallah IPO P/E ratio of -116.86.
| Gujarat Kidney IPO | PhysicsWallah IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)Gujarat Kidney & Super Speciality Ltd.'s revenue increased by 637% and profit after tax (PAT) rose by 454% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated Consolidated)PhysicsWallah Ltd.'s revenue increased by 51% and profit after tax (PAT) rose by 78% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 99.1 | 81.64 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 71.45 | 71.48 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 61.62 | -116.86 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹898.81 Cr. | ₹31526.73 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 36.61% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 37.65% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.15 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹1.85 | ₹-0.93 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 36.61% | -12.50% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Gujarat Kidney IPO Retail Individual Investors (RII) are offered 22,00,000 shares while in PhysicsWallah IPO retail investors are offered 22,00,000 shares. Qualified Institutional Buyers (QIB) are offered 77,26,880 shares in Gujarat Kidney IPO and 9,55,87,156 shares in PhysicsWallah IPO.
| Gujarat Kidney IPO | PhysicsWallah IPO | |
|---|---|---|
| Anchor Investor Reservation | 87,73,120 shares | 14,33,80,733 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 77,26,880 shares | 9,55,87,156 shares |
| NII | 33,00,000 shares | 4,77,93,577 shares |
| RII | 22,00,000 shares | 3,18,62,385 shares |
| Employee | 0 shares | 7,07,070 shares |
| Others | ||
| Total | 2,20,00,000 shares | 31,93,30,921 shares |
Gujarat Kidney IPO subscribed 5.21x in total, whereas PhysicsWallah IPO subscribed 1.92x.
| Gujarat Kidney IPO | PhysicsWallah IPO | |
|---|---|---|
| QIB (times) | 1.06x | 2.86x |
| NII (times) | 5.73x | 0.51x |
| Big NII (times) | 5.25x | 0.58x |
| Small NII (times) | 6.68x | 0.37x |
| RII (times) | 19.04x | 1.14x |
| Employee (times) | 3.71x | |
| Other (times) | ||
| Total (times) | 5.21x | 1.92x |
